RIPK3 and cholangiocarcinoma: RIPK3 immunoreactivity was differentially present and mainly localized in the cytoplasm of CCA tissues, normal cholangiocyte adjacent to tumor tissues, and cholangiocytes from normal liver tissues (Fig. 1A, Supplementary Fig. S1A).